APA (7th ed.) Citation

Gupta-Werner, N., Khare, V., Macomson, B., & Medhekar, R. (2025). Cost of Anti-CD38 Monoclonal Antibodies in Combination With Bortezomib, Lenalidomide and Dexamethasone for the Frontline Treatment of Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma in the US. Columbia Data Analytics, LLC.

Chicago Style (17th ed.) Citation

Gupta-Werner, Niodita, Vipin Khare, Brian Macomson, and Rohan Medhekar. Cost of Anti-CD38 Monoclonal Antibodies in Combination With Bortezomib, Lenalidomide and Dexamethasone for the Frontline Treatment of Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma in the US. Columbia Data Analytics, LLC, 2025.

MLA (9th ed.) Citation

Gupta-Werner, Niodita, et al. Cost of Anti-CD38 Monoclonal Antibodies in Combination With Bortezomib, Lenalidomide and Dexamethasone for the Frontline Treatment of Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma in the US. Columbia Data Analytics, LLC, 2025.